Patriot Investment Management Inc. Takes $316,000 Position in SPDR S&P Biotech ETF (XBI)

Patriot Investment Management Inc. bought a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,496 shares of the exchange traded fund’s stock, valued at approximately $316,000.

A number of other large investors have also bought and sold shares of the stock. JPMorgan Chase & Co. boosted its holdings in shares of SPDR S&P Biotech ETF by 98.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,265,715 shares of the exchange traded fund’s stock worth $313,084,000 after buying an additional 1,622,372 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of SPDR S&P Biotech ETF by 7.0% during the 3rd quarter. Bank of New York Mellon Corp now owns 21,854 shares of the exchange traded fund’s stock worth $2,095,000 after buying an additional 1,435 shares in the last quarter. FMR LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 2.4% in the 3rd quarter. FMR LLC now owns 40,967 shares of the exchange traded fund’s stock worth $3,927,000 after purchasing an additional 975 shares in the last quarter. Neuberger Berman Group LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 334.2% in the 3rd quarter. Neuberger Berman Group LLC now owns 10,855 shares of the exchange traded fund’s stock worth $1,041,000 after purchasing an additional 8,355 shares in the last quarter. Finally, Marshall Wace LLP bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $1,615,000.

Shares of XBI opened at $86.21 on Friday. SPDR S&P Biotech ETF has a 12-month low of $64.38 and a 12-month high of $101.55.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.baseballdailydigest.com/news/2019/05/05/patriot-investment-management-inc-takes-316000-position-in-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: What is the balance sheet?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.